Screening of phytochemicals as potent inhibitor of 3-chymotrypsin and papain-like proteases of SARS-CoV2: an in silico approach to combat COVID-19

References

• Banerjee, T., Valacchi, G., Ziboh, V. A., & van der Vliet, A. (2002). Inhibition of TNFα-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-κB activation in A549 cells. Molecular and Cellular Biochemistry, 238(1–2), 105–110. https://doi.org/https://doi.org/10.1023/A:1019963222510
   PubMed Web of Science ®Google Scholar
• Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti, S., & Ciccozzi, M. (2020). The 2019-new Coronavirus epidemic: Evidence for virus evolution. Journal of Medical Virology, 92(4), 455–459. https://doi.org/https://doi.org/10.1002/jmv.25688
   PubMed Web of Science ®Google Scholar
• Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, 178 (2020), 104787. https://doi.org/https://doi.org/10.1016/j.antiviral.2020.104787
   PubMed Web of Science ®Google Scholar
• Chen, C.-N., Lin, C. P. C., Huang, K.-K., Chen, W.-C., Hsieh, H.-P., Liang, P.-H., & Hsu, J. T.-A. (2005). Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3'-digallate (TF3). Evidence-Based Complementary and Alternative Medicine: ECAM, 2(2), 209–215. https://doi.org/https://doi.org/10.1093/ecam/neh081
   PubMed Web of Science ®Google Scholar
• Chojnacka, K., Witek-Krowiak, A., Skrzypczak, D., Mikula, K., & Młynarz, P. (2020). Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus. Journal of Functional Foods, 73, 104146. https://doi.org/https://doi.org/10.1016/j.jff.2020.104146
   PubMed Web of Science ®Google Scholar
• Cui, J., Li, F., & Shi, Z. (2019). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology, 17(3), 181–192. https://doi.org/https://doi.org/10.1038/s41579-018-0118-9
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.https://doi.org/https://doi.org/10.1038/srep42717.
   PubMed Web of Science ®Google Scholar
• Dickson, C. J., Madej, B. D., Skjevik, A. A., Betz, R. M., Teigen, K., Gould, I. R., & Walker, R. C. (2014). Lipid14: The amber lipid force field. Journal of Chemical Theory and Computation, 10(2), 865–879. https://doi.org/https://doi.org/10.1021/ct4010307
   PubMed Web of Science ®Google Scholar
• DiMasi, J. A., Hansen, R. G., & Grabowski, H. G. (2003). The price of innovation: New estimates of drug development costs. Journal of Health Economics, 22(2), 151–185. https://doi.org/https://doi.org/10.1016/S0167-6296(02)00126-1
   PubMed Web of Science ®Google Scholar
• Dong, J., Wang, N.-N., Yao, Z.-J., Zhang, L., Cheng, Y., Ouyang, D., Lu, A.-P., & Cao, D.-S. (2018). ADMETlab: A platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. Journal of Cheminformatics, 10(1), 29. doi: https://doi.org/10.1155/2012/281078.
   PubMed Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117477
   PubMed Web of Science ®Google Scholar
• Forni, D., Cagliani, R., Clerici, M., & Sironi, M. (2017). Molecular evolution of human coronavirus genomes. Trends in Microbiology, 25(1), 35–48. https://doi.org/https://doi.org/10.1016/j.tim.2016.09.001
   PubMed Web of Science ®Google Scholar
• Gandhi, R. T., Lynch, J. B., & Rio, C. (2020). Mild or moderate covid-19. New England Journal of Medicine. https://doi.org/https://doi.org/10.1056/NEJMcp2009249.
   Google Scholar
• Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020). Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – an in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1779818
   Google Scholar
• Gilson, M. K., & Honig, B. (1988). Calculation of the total electrostatic energy of a macromolecular system: Solvation energies, binding energies, and conformational analysis. Proteins, 4(1), 7–18. https://doi.org/https://doi.org/10.1002/prot.340040104
   PubMed Web of Science ®Google Scholar
• Gogoi, A., Dutta, D., Verma, A. K., Nath, H., Frontera, A., Guha, A. K., & Bhattacharyya, M. K. (2019). Energetically favorable anti-electrostatic hydrogen bonded cationic clusters in Ni (II) 3,5-dimethylpyrazole complexes: Anticancer evaluation and theoretical studies. Polyhedron, 168, 113–126. https://doi.org/https://doi.org/10.1016/j.poly.2019.04.043
   Web of Science ®Google Scholar
• Guan, L., Yang, H., Cai, Y., Sun, L., Di, P., Li, W., Liu, G., & Tang, Y. (2019). ADMET-score - A comprehensive scoring function for evaluation of chemical drug-likeness. MedChemComm, 10(1), 148–157. https://doi.org/https://doi.org/10.1039/c8md00472b
   PubMed Web of Science ®Google Scholar
• Gyebi, G. A., Ogunro, O. B., Adegunloye, A. P., Ogunyemi, O. M., & Afolabi, S. O. (2020). Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1764868.
   Web of Science ®Google Scholar
• Hawas, U. W., El-Kassem, L. T., Shaher, F., & Al-Farawati, R. (2019). In vitro inhibition of Hepatitis C virus protease and antioxidant by flavonoid glycosides from the Saudi costal plant Sarcocornia fruticosa. Natural Product Research, 33(23), 3364–3371. https://doi.org/https://doi.org/10.1080/14786419.2018.1477153
   PubMed Web of Science ®Google Scholar
• Islam, M. J., Parves, M. R., Mahmud, S., Tithi, F. A., & Reza, M. A. (2019). Assessment of structurally and functionally high-risk nsSNPs impacts on human bone morphogenetic protein receptor type IA (BMPR1A) by computational approach. Computational Biology and Chemistry, 80(2019), 31–45.https://doi.org/https://doi.org/10.1016/j.compbiolchem.2019.03.00.
   PubMed Web of Science ®Google Scholar
• Jayadevappa, M. K., Karkera, P. R., Siddappa, R. Y., Telkar, S., & Karunakara, P. (2020). Investigation of plant flavonoids as potential dengue protease inhibitors. Journal of Herbmed Pharmacology, 9(4), 366–373. https://doi.org/https://doi.org/10.34172/jhp.2020.46
   Google Scholar
• Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
   PubMed Web of Science ®Google Scholar
• Khan, M. A., Mahmud, S., Alam, A. S. M. R. U., Rahman, M. E., Ahmed, F., & Rahmatullah, M. (2020). Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: A molecular docking study. Journal of Biomolecular Structure and Dynamics, 1-7. https://doi.org/https://doi.org/10.1080/07391102.2020.1796813.
   Google Scholar
• Kim, D. W., Seo, K. H., Curtis-Long, M. J., Oh, K. Y., Oh, J.-W., Cho, J. K., Lee, K. H., & Park, K. H. (2014). Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. Journal of Enzyme Inhibition and Medicinal Chemistry, 29(1), 59–63. https://doi.org/https://doi.org/10.3109/14756366.2012.753591
   PubMed Web of Science ®Google Scholar
• Krieger E., Elmar, G. V., & Spronk, C. (2003). YASARA – Yet another scientific artificial reality application. www.yasara.org
   Google Scholar
• Krieger, E., Nielsen, J. E., Spronk, C. A. E. M., & Vriend, G. (2006). Fast empirical pKa prediction by Ewald summation. Journal of Molecular Graphics & Modelling, 25(4), 481–486. https://doi.org/https://doi.org/10.1016/j.jmgm.2006.02.009
   PubMed Web of Science ®Google Scholar
• Krieger, E., & Vriend, G. (2015). New ways to boost molecular dynamics simulations. Journal of Computational Chemistry, 36(13), 996–1007. https://doi.org/https://doi.org/10.1002/jcc.23899
   PubMed Web of Science ®Google Scholar
• Laskar, M. A., & Choudhury, M. D. (2020). Search for therapeutics against COVID 19 targeting SARS-CoV-2 papain-like protease: An in silico study. ResearchSquare (Preprint). https://doi.org/https://doi.org/10.21203/rs.3.rs-33294/v1.
   Google Scholar
• Lee, J., Oh, W. K., Ahn, J. S., Kim, Y. H., Mbafor, J. T., Wandji, J., & Fomum, Z. T. (2009). Prenylisoflavonoids from Erythrina senegalensis as novel HIV-1 protease inhibitors. Planta Medica, 75(3), 268–270. https://doi.org/https://doi.org/10.1055/s-0028-1088395
   PubMed Web of Science ®Google Scholar
• Lee, J. S., Sul, J. Y., Park, J. B., Lee, M. S., Cha, E. Y., Song, I. S., Kim, J. R., & Chang, E. S. (2013). Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells. Phytotherapy Research: PTR, 27(5), 713–720. 0https://doi.org/https://doi.org/10.1002/ptr.4778
   PubMed Web of Science ®Google Scholar
• Lin, C.-W., Tsai, F.-J., Tsai, C.-H., Lai, C.-C., Wan, L., Ho, T.-Y., Hsieh, C.-C., & Chao, P.-D L. (2005). Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Research, 68(1), 36–42. https://doi.org/https://doi.org/10.1016/j.antiviral.2005.07.002
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today Technologies, 1(4), 337–341. http:// https://doi.org/https://doi.org/10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Liu, H., Ye, F., Sun, Q., Liang, H., Li, C., & Lu, R. (2020). Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in-vitro. BioRxiv. https://doi.org/https://doi.org/10.1101/2020.04.10.035824.
   Google Scholar
• Mahmud, S., Parves, M. R., Riza, Y. M., Sujon, K. M., Ray, S., Tithi, F. A., Zaoti, Z. F., Alam, S., & Absar N. (2020a). Exploring the potent inhibitors and binding modes of phospholipase A2 through in silico investigation. Journal of Biomolecular Structure and Dynamics, 38(14), 4221–4231. https://doi.org/https://doi.org/10.1080/07391102.2019.1680440.
   Google Scholar
• Mahmud, S., Uddin, M. A. R., Zaman, M., Sujon, K. M., Rahman, M. E., & Shehab, M. N. (2020b). Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1-9. https://doi.org/https://doi.org/10.1080/07391102.2020.1796808.
   Google Scholar
• Mishra, A., Pathak, Y., Choudhir, G., Kumar, A., Mishra, S. K., & Tripathi, V. (2020). Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico study. ResearchSquare (Preprint). https://doi.org/https://doi.org/10.21203/rs.3.rs-22839/v2.
   Google Scholar
• Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020). Learning from the past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem: A European Journal of Chemical Biology, 21(5), 730–738. https://doi.org/https://doi.org/10.1002/cbic.202000047
   PubMed Web of Science ®Google Scholar
• Muchtaridi, M., Syahidah, H. N., Subarnas, A., Yusuf, M., Bryant, S. D., & Langer, T. (2017). Molecular Docking and 3d-pharmacophore modeling to study the interactions of chalcone derivatives with estrogen receptor alpha. Pharmaceuticals, 10(4), 81. https://doi.org/https://doi.org/10.3390/ph10040081
   Web of Science ®Google Scholar
• Nguyen, T. T. H., Woo, H.-J., Kang, H.-K., Nguyen, V. D., Kim, Y.-M., Kim, D.-W., Ahn, S.-A., Xia, Y., & Kim, D. (2012). Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnology Letters, 34(5), 831–838. https://doi.org/https://doi.org/10.1007/s10529-011-0845-8
   PubMed Web of Science ®Google Scholar
• Nutan, M. M., Goel, T., Das, T., Malik, S., & Suri, S. (2013). Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity. Indian Journal of Medical Research, 137, 540–548.
   PubMed Web of Science ®Google Scholar
• O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 1-14. https://doi.org/https://doi.org/10.1186/1758-2946-3-33.
   Google Scholar
• Okebe, J., Bojang, K., & D'Alessandro, U. (2014). Use of artemisinin and its derivatives for the treatment of malaria in children. The Pediatric Infectious Disease Journal, 33(5), 522–524. https://doi.org/https://doi.org/10.1097/INF.0000000000000306
   PubMed Web of Science ®Google Scholar
• Omolo, C. A., Soni, N., Fasiku, V. O., Mackraj, I., & Govender, T. (2020). Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus. European Journal of Pharmacology, 883, 173348. https://doi.org/https://doi.org/10.1016/j.ejphar.2020.173348
   PubMed Web of Science ®Google Scholar
• Pan, X., Tan, N., Zeng, G., Zhang, Y., & Jia, R. (2005). Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B. Bioorganic & Medicinal Chemistry, 13(20), 5819–5825. https://doi.org/https://doi.org/10.1016/j.bmc.2005.05.071
   PubMed Web of Science ®Google Scholar
• Pandey, P., Rane, J. S., Chatterjee, A., Kumar, A., Khan, R., Prakash, A., & Ray, S. (2020). Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in silico study for drug development. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1796811.
   Google Scholar
• Park, J.-Y., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, S.-J., Kim, D., Park, K. H., Lee, W. S., & Ryu, Y. B. (2012). Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biological & Pharmaceutical Bulletin, 35(11), 2036–2042. https://doi.org/https://doi.org/10.1248/bpb.b12-00623
   PubMed Web of Science ®Google Scholar
• Park, J.-Y., Kim, J. H., Kwon, J. M., Kwon, H.-J., Jeong, H. J., Kim, Y. M., Kim, D., Lee, W. S., & Ryu, Y. B. (2013). Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorganic & Medicinal Chemistry, 21(13), 3730–3737. https://doi.org/https://doi.org/10.1016/j.bmc.2013.04.026
   PubMed Web of Science ®Google Scholar
• Park, J.-Y., Ko, J.-A., Kim, D. W., Kim, Y. M., Kwon, H.-J., & Jeong, H. J. (2016). Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. Journal of Biomolecular Structure and Dynamics, 31. https://doi.org/https://doi.org/10.3109/14756366.2014.1003215.
   Google Scholar
• Park, J.-Y., Yuk, H. J., Ryu, H. W., Lim, S. H., Kim, K. S., Park, K. H., Ryu, Y. B., & Lee, W. S. (2017). Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 504–512. https://doi.org/https://doi.org/10.1080/14756366.2016.1265519
   PubMed Web of Science ®Google Scholar
• Qamar, M. T., Alqahtani, S. M., Alamri, M. A., & Chen, L. L. (2020). Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. Journal of Pharmaceutical Analysis. https://doi.org/https://doi.org/10.1016/j.jpha.2020.03.009.
   Google Scholar
• Razzaghi-Asl, N., Mirzayi, S., Mahnam, K., & Sepehri, S. (2018). Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation. Journal of Molecular Graphics & Modelling, 83, 138–152. https://doi.org/https://doi.org/10.1016/j.jmgm.2018.05.010
   PubMed Web of Science ®Google Scholar
• Ryu, Y. B., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, J.-Y., Kim, D., Nguyen, T. T. H., Park, S.-J., Chang, J. S., Park, K. H., Rho, M.-C., & Lee, W. S. (2010). Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorganic & Medicinal Chemistry, 18(22), 7940–7947. https://doi.org/https://doi.org/10.1016/j.bmc.2010.09.035
   PubMed Web of Science ®Google Scholar
• Ryu, Y. B., Park, S.-J., Kim, Y. M., Lee, J.-Y., Seo, W. D., Chang, J. S., Park, K. H., Rho, M.-C., & Lee, W. S. (2010). SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorganic & Medicinal Chemistry Letters, 20(6), 1873–1876. https://doi.org/https://doi.org/10.1016/j.bmcl.2010.01.152
   PubMed Web of Science ®Google Scholar
• Shin D. H., Bae, Y. C., Kim‐Han, J. S., Lee, J. H., Choi, I. Y., Ho, K., Sik Kang, S. S., Kim, W., & Han, B. Y. (2006). Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms . Journal of Neurochemistry, 96(2), 561–572. https://doi.org/https://doi.org/10.1111/j.1471-4159.2005.03582.x
   PubMed Web of Science ®Google Scholar
• Song, Y. H., Kim, D. W., Curtis-Long, M. J., Yuk, H. J., Wang, Y., Zhuang, N., Lee, K. H., Jeon, K. S., & Park, K. H. (2014). Papain-like protease (plpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. Biological & Pharmaceutical Bulletin, 37(6), 1021–1028. https://doi.org/https://doi.org/10.1248/bpb.b14-00026
   PubMed Web of Science ®Google Scholar
• Strodel, B., Olubiyi, O., Olagunju, M., Keutmann, M., & Loschwitz, J. (2020). High throughput virtual screening to discover inhibitors of the main protease of the coronavirus SARS-CoV-2. Preprints. https://doi.org/https://doi.org/10.20944/preprints202004.0161.v1
   Google Scholar
• Sun, C. M., Yu, S. L., Ou, J. C., & Syu, W. J. (1995). Test of the biflavones from Selaginella moellendorffii on the in vitro inhibition of HIV-1 protease. Journal of Traditional Chinese Medicine, 6(3), 223–230.
   Google Scholar
• Swargiary, A., Verma, A. K., Singh, S., Roy, M. K., & Daimari, M. (2020). Antioxidant and antiproliferative activity of selected medicinal plants of lower Assam, India: An in vitro and in silico study. Anti-Cancer Agent in Medical Chemistry. https://doi.org/https://doi.org/10.2174/1871520620666200719000449
   Google Scholar
• Tang, X., Wu, C., Li, X., Song, Y., Yao, X., Wu, X., Duan, Y., Zhang, H., Wang, Y., Qian, Z., Cui, J., & Lu, J. (2020). On the origin and continuing evolution of SARS-CoV-2. National Science Review, 7(6), 1012–1023. https://doi.org/https://doi.org/10.1093/nsr/nwaa036
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. http:// https://doi.org/https://doi.org/10.1002/jcc.21334
   Google Scholar
• Vardhan, S., & Sahoo, S. K. (2020). In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Computers in Biology and Medicine, 124, 103936. https://doi.org/https://doi.org/10.1016/j.compbiomed.2020.103936
   Google Scholar
• Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/https://doi.org/10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Wen, C.-C., Kuo, Y.-H., Jan, J.-T., Liang, P.-H., Wang, S.-Y., Liu, H.-G., Lee, C.-K., Chang, S.-T., Kuo, C.-J., Lee, S.-S., Hou, C.-C., Hsiao, P.-W., Chien, S.-C., Shyur, L.-F., & Yang, N.-S. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. Journal of Medicinal Chemistry, 50(17), 4087–4095. https://doi.org/https://doi.org/10.1021/jm070295s
   Google Scholar
• Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766–788. https://doi.org/https://doi.org/10.1016/j.apsb.2020.02.008
   PubMed Web of Science ®Google Scholar
• Zhou, H., Fang, Y., Xu, T., Ni, W., Shen, A., & Meng, X. (2020). Potential therapeutic targets and promising drugs for combating SARS-CoV-2. British Journal of Pharmacology, 177(14), 3147–3161. https://doi.org/https://doi.org/10.1111/bph.15092
   Google Scholar
• Zhou, J., Fang, L., Yang, Z., Xu, S., Lv, M., Sun, Z., Chen, J., Wang, D., Gao, J., & Xiao, S. (2019). Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 33(12), 14575–14587. https://doi.org/https://doi.org/10.1096/fj.201901624RR
   PubMed Web of Science ®Google Scholar